140 related articles for article (PubMed ID: 35779808)
1. System-Level Capacity of High-Dose Rate (HDR) Brachytherapy for Management of Cervical Cancer in an Upper-Middle Income Country: A Case Study From Brazil.
Gouveia AG; Viani GA; Bratti VF; Pavoni JF; Sullivan R; Rosa AA; Booth CM; Aggarwal A; Hanna TP; Moraes FY
Int J Radiat Oncol Biol Phys; 2022 Nov; 114(3):545-553. PubMed ID: 35779808
[TBL] [Abstract][Full Text] [Related]
2. Prioritising locations for radiotherapy equipment in Brazil: a cross-sectional, population-based study and development of a LINAC shortage index.
Viani GA; Gouveia AG; Bratti VF; Pavoni JF; Sullivan R; Hopman WM; Booth CM; Aggarwal A; Hanna TP; Moraes FY
Lancet Oncol; 2022 Apr; 23(4):531-539. PubMed ID: 35298907
[TBL] [Abstract][Full Text] [Related]
3. Radiotherapy resources in Latin America and the Caribbean: a review of current and projected needs based on International Atomic Energy Agency data.
Elbanna M; Pynda Y; Kalinchuk O; Rosa A; Abdel-Wahab M
Lancet Oncol; 2023 Sep; 24(9):e376-e384. PubMed ID: 37657478
[TBL] [Abstract][Full Text] [Related]
4. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
Eifel PJ; Moughan J; Owen J; Katz A; Mahon I; Hanks GE
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):351-8. PubMed ID: 10030261
[TBL] [Abstract][Full Text] [Related]
5. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
6. High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer.
Wang X; Liu R; Ma B; Yang K; Tian J; Jiang L; Bai ZG; Hao XY; Wang J; Li J; Sun SL; Yin H
Cochrane Database Syst Rev; 2010 Jul; (7):CD007563. PubMed ID: 20614461
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy resources in Brazil (RT2030): a comprehensive analysis and projections for 2030.
Rosa AA; de Sousa CFPM; Pimentel LCF; Martins HL; Moraes FY; Marta GN; Castilho MS
Lancet Oncol; 2023 Aug; 24(8):903-912. PubMed ID: 37541272
[TBL] [Abstract][Full Text] [Related]
8. Surveying the Challenges to Improve Linear Accelerator-based Radiation Therapy in Africa: a Unique Collaborative Platform of All 28 African Countries Offering Such Treatment.
Ige TA; Jenkins A; Burt G; Angal-Kalinin D; McIntosh P; Coleman CN; Pistenmaa DA; O'Brien D; Dosanjh M
Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e521-e529. PubMed ID: 34116903
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic significance of magnetic resonance imaging in patients with cervical cancer after brachytherapy: a meta-analysis.
Zhang J; Tian W; Bu X; Wang X; Tian F; Wu L
Acta Radiol; 2019 May; 60(5):670-676. PubMed ID: 30149749
[TBL] [Abstract][Full Text] [Related]
10. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
[TBL] [Abstract][Full Text] [Related]
11. American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries.
Suneja G; Brown D; Chang A; Erickson B; Fidarova E; Grover S; Mahantshetty U; Nag S; Narayan K; Bvochora-Nsingo M; Viegas C; Viswanathan AN; Lin MY; Gaffney D
Brachytherapy; 2017; 16(1):85-94. PubMed ID: 27919654
[TBL] [Abstract][Full Text] [Related]
12. High versus low dose rate intracavitary irradiation for adenocarcinoma of the uterine cervix.
Kim WC; Kim GE; Suh CO; Loh JJ
Jpn J Clin Oncol; 2001 Sep; 31(9):432-7. PubMed ID: 11689597
[TBL] [Abstract][Full Text] [Related]
13. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
[TBL] [Abstract][Full Text] [Related]
14. Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.
Lee SW; Suh CO; Chung EJ; Kim GE
Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1338-44. PubMed ID: 11955747
[TBL] [Abstract][Full Text] [Related]
15. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
16. A population-based study of cervix cancer: incidence, management and outcome in the Canadian province of Saskatchewan.
Mahmud A; Brydon B; Tonita J; Hanna TP; Schmidt M; Tai P
Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):691-5. PubMed ID: 21646003
[TBL] [Abstract][Full Text] [Related]
17. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
[TBL] [Abstract][Full Text] [Related]
18. Low-dose-rate vs. high-dose-rate intracavitary brachytherapy for carcinoma of the cervix: The University of Alabama at Birmingham (UAB) experience.
Falkenberg E; Kim RY; Meleth S; De Los Santos J; Spencer S
Brachytherapy; 2006; 5(1):49-55. PubMed ID: 16563997
[TBL] [Abstract][Full Text] [Related]
19. Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.
Rodin D; Burger EA; Atun R; Barton M; Gospodarowicz M; Grover S; Hanna TP; Jaffray DA; Knaul FM; Lievens Y; Zubizarreta E; Milosevic M
Lancet Oncol; 2019 Jul; 20(7):915-923. PubMed ID: 31151906
[TBL] [Abstract][Full Text] [Related]
20. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
